SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects

被引：119
|
作者：
Lam, Carolyn S. P. [1 ,2 ,3 ,4 ]
Chandramouli, Chanchal [1 ]
Ahooja, Vineeta [5 ]
Verma, Subodh [6 ,7 ]
机构：
[1] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore
[2] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] George Inst Global Hlth, Newtown, Tas, Australia
[5] Heart Hlth Inst, Toronto, ON, Canada
[6] Univ Toronto, Keenan Res Ctr Biomed Sci, Div Cardiac Surg, St Michaels Hosp, Toronto, ON, Canada
[7] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 20期
关键词：
heart failure; SGLT-2; inhibitors; type 2 diabetes mellitus; unmet needs; ASSOCIATION TASK-FORCE; 2013 ACCF/AHA GUIDELINE; NONCARDIAC COMORBIDITIES; CARDIOVASCULAR OUTCOMES; AMERICAN-COLLEGE; DIABETES-MELLITUS; EJECTION FRACTION; NA+/H+-EXCHANGER; CARDIAC FIBROSIS; FOCUSED UPDATE;
D O I：
10.1161/JAHA.119.013389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Double Edged Sword: SGLT-2 Inhibitors in the Immunosuppressed Heart Failure Patient
    Brown, Christina
    Addis, Jessica
    Mohamed, Fazad
    CIRCULATION, 2023, 148
  • [22] Lessons from SGLT-2 inhibitors: rethinking endpoints for heart failure studies
    Sheng Fu
    Sheldon E. Litwin
    Ryan J. Tedford
    Nature Medicine, 2021, 27 : 1872 - 1873
  • [23] SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
    Ferro, Enrico G.
    Pitt, Bertram
    Bhatt, Deepak L.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (11) : 601 - 606
  • [24] EMPULSE trial: Time to use SGLT-2 inhibitors in acute heart failure?
    Roy, Shubhajeet
    Saxena, Mehul
    Pradhan, Akshyaya
    NATIONAL MEDICAL JOURNAL OF INDIA, 2024, 37 (02): : 93 - 94
  • [25] ADHERENCE TO SGLT-2 INHIBITORS ACROSS THE SPECTRUM OF HEART FAILURE: A SOCIOECONOMIC DISPARITY?
    Somoza-Cano, Francisco J.
    Sakamuri, Laxmi
    Amoah, Joseph
    Pineda, Allan Bueso
    Houry, Ahmad
    Argueta, Allan Santos
    Velasquez, Adolfo
    Mogollon, Ivan
    Mantilla, Diego Andres Padilla
    Somoza, Francisco Ramon
    Ravakhah, Keyvan
    CHEST, 2024, 166 (04) : 579A - 580A
  • [26] Lessons from SGLT-2 inhibitors: rethinking endpoints for heart failure studies
    Fu, Sheng
    Litwin, Sheldon E.
    Tedford, Ryan J.
    NATURE MEDICINE, 2021, 27 (11) : 1872 - 1873
  • [27] Expect the Unexpected: SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes and/or Heart Failure
    Seferovic, Jelena P.
    Seferovic, Petar M.
    CARDIOLOGY, 2020, 145 (05) : 321 - 323
  • [28] Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
    Frak, Weronika
    Hajdys, Joanna
    Radzioch, Ewa
    Szlagor, Magdalena
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    BIOMEDICINES, 2023, 11 (07)
  • [29] SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness
    Ilaria Cavallari
    Ernesto Maddaloni
    Annunziata Nusca
    Dario Tuccinardi
    Raffaella Buzzetti
    Paolo Pozzilli
    Francesco Grigioni
    American Journal of Cardiovascular Drugs, 2022, 22 : 263 - 270
  • [30] SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness
    Cavallari, Ilaria
    Maddaloni, Ernesto
    Nusca, Annunziata
    Tuccinardi, Dario
    Buzzetti, Raffaella
    Pozzilli, Paolo
    Grigioni, Francesco
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 263 - 270
12345